Ascletis Pharma Inc. (ASCLF)
USD 0.81
(-12.29%)
USD 0.81
(-12.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 56.59 Million CNY | 4.63% |
| 2022 | 54.09 Million CNY | -29.64% |
| 2021 | 76.87 Million CNY | 119.64% |
| 2020 | 35 Million CNY | -79.82% |
| 2019 | 173.44 Million CNY | 4.28% |
| 2018 | 166.32 Million CNY | 212.63% |
| 2017 | 53.2 Million CNY | 61.34% |
| 2016 | 32.97 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 56.59 Million CNY | 4.63% |
| 2023 Q4 | 1.39 Million USD | 0.0% |
| 2023 Q2 | 6.7 Million USD | 0.0% |
| 2022 FY | 54.09 Million CNY | -29.64% |
| 2022 Q2 | 5.87 Million USD | 0.0% |
| 2022 Q4 | 2.27 Million USD | 0.0% |
| 2021 Q2 | 5.64 Million USD | 0.0% |
| 2021 Q4 | 6.25 Million USD | 0.0% |
| 2021 FY | 76.87 Million CNY | 119.64% |
| 2020 FY | 35 Million CNY | -79.82% |
| 2020 Q2 | 4.53 Million USD | 0.0% |
| 2020 Q4 | 467.36 Thousand USD | 0.0% |
| 2019 Q4 | 14 Million USD | 0.0% |
| 2019 FY | 173.44 Million CNY | 4.28% |
| 2019 Q2 | 11.15 Million USD | 0.0% |
| 2018 Q2 | 64.06 Million CNY | 25.46% |
| 2018 FY | 166.32 Million CNY | 212.63% |
| 2018 Q1 | 51.06 Million CNY | 0.0% |
| 2017 Q2 | 13.3 Million CNY | -0.01% |
| 2017 FY | 53.2 Million CNY | 61.34% |
| 2017 Q1 | 13.3 Million CNY | 0.0% |
| 2016 FY | 32.97 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bioxytran, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -258.816% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -163.507% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -86006.378% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -210.66% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | 53.97% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 645.81 Thousand USD | -8663.568% |
| Genus plc | 668.8 Million USD | 91.538% |
| Pharming Group N.V. | 245.31 Million USD | 76.929% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -57071.142% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -13698.349% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -73630.149% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -143115.75% |
| ONE Bio Corp. | 52.29 Million USD | -8.222% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -13.827% |
| Mesoblast Limited | 5.9 Million USD | -858.929% |
| MultiCell Technologies, Inc. | 49.32 USD | -114752535.848% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -91.222% |
| Genscript Biotech Corporation | 839.52 Million USD | 93.259% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -321084.95% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -10047.926% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -80751.429% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -74639.845% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -8494.685% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -115638.241% |
| Q BioMed Inc. | 284.35 Thousand USD | -19803.5% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 99.615% |
| Agentix Corp. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 60.995% |
| Enzolytics Inc. | 52.79 Thousand USD | -107097.515% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -9200.522% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 95.385% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -2829.4% |
| HST Global, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -5665165.265% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -40255.956% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -9067.066% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -5572.499% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -17.045% |
| Kadimastem Ltd | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -239.195% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -23824.586% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -23824.586% |
| Affymax, Inc. | 1.36 Million USD | -4034.112% |
| Mobile Lads Corp. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -626.614% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -11846.89% |
| SYBLEU INC | 11.69 Thousand USD | -483791.929% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -435253.846% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -143057.788% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -1599.58% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -749.152% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -5347.161% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -119.645% |
| CSL Limited | 14.8 Billion USD | 99.618% |
| Cellectis S.A. | 755 Thousand USD | -7396.159% |